© 2000 by Oxford University Press
Journal of the National Cancer Institute, Vol. 92, No. 21, 1717-1730,
November 1, 2000
© 2000 Oxford University Press
REVIEW |
Metastasis-Suppressor Genes: a Review and Perspective on an Emerging Field
Affiliations of authors: B. A. Yoshida, M. M. Sokoloff, C. W. Rinker-Schaeffer, Section of Urology and Genitourinary Oncology Research Program of the University of Chicago, IL; D. R. Welch, The Jake Gittlen Cancer Research Institute, The Pennsylvania State University College of Medicine, Hershey.
Correspondence to: Carrie W. Rinker-Schaeffer, Ph.D., Section of Urology, Department of Surgery MC6038, The University of Chicago, 5831 S. Maryland Ave., Chicago, IL 60637 (e-mail: crinker{at}surgery.bsd.uchicago.edu).
Metastasis is the most lethal attribute of a cancer. There is a critical need for markers that will distinguish accurately those histologic lesions and disseminated cells with a high probability of causing clinically important metastatic disease from those that will remain indolent. While the development of new diagnostic markers of metastasis was the initial motivation for many studies, the biologic approach used to identify metastasis-suppressor genes has provided surprising insights into the in vivo mechanisms regulating the formation of metastases. This review and perspective describes the evolving view of the mechanisms that regulate metastasis and the importance of metastasis-suppressor genes in this process. The known metastasis-suppressor proteins or genes and the microcell-mediated chromosomal transfer strategy used to identify many of them are reviewed. New evidence for the role of these metastasis-suppressor proteins or genes in regulating the growth of disseminated cancer cells at the secondary site, the potential for the identification of novel therapeutic targets, and the multidisciplinary approach needed to translate this information into clinical tools for the treatment of metastatic disease are discussed.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  H. Z. Li, Y. Wang, Y. Gao, J. Shao, X. L. Zhao, W. M. Deng, Y. X. Liu, J. Yang, and Z. Yao Effects of Raf Kinase Inhibitor Protein Expression on Metastasis and Progression of Human Epithelial Ovarian Cancer Mol. Cancer Res., June 1, 2008; 6(6): 917 - 928. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C.-C. Wu, J.-C. Lin, S.-C. Yang, C.-W. Lin, J. J.W. Chen, J.-Y. Shih, T.-M. Hong, and P.-C. Yang Modulation of the expression of the invasion-suppressor CRMP-1 by cyclooxygenase-2 inhibition via reciprocal regulation of Sp1 and C/EBP{alpha} Mol. Cancer Ther., June 1, 2008; 7(6): 1365 - 1375. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. S. Singh, M. Berk, R. Oates, Z. Zhao, H. Tan, Y. Jiang, A. Zhou, K. Kirmani, R. Steinmetz, D. Lindner, et al. Ovarian Cancer G Protein Coupled Receptor 1, a New Metastasis Suppressor Gene in Prostate Cancer J Natl Cancer Inst, September 5, 2007; 99(17): 1313 - 1327. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Pentheroudakis, E. Briasoulis, and N. Pavlidis Cancer of Unknown Primary Site: Missing Primary or Missing Biology? Oncologist, April 1, 2007; 12(4): 418 - 425. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. M. K. Pulukuri, N. Estes, J. Patel, and J. S. Rao Demethylation-Linked Activation of Urokinase Plasminogen Activator Is Involved in Progression of Prostate Cancer Cancer Res., February 1, 2007; 67(3): 930 - 939. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. G. Hicks, B. J. Yoder, S. Short, S. Tarr, N. Prescott, J. P. Crowe, A. E. Dawson, G. T. Budd, S. Sizemore, M. Cicek, et al. Loss of Breast Cancer Metastasis Suppressor 1 Protein Expression Predicts Reduced Disease-Free Survival in Subsets of Breast Cancer Patients. Clin. Cancer Res., November 15, 2006; 12(22): 6702 - 6708. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Zhang, H. Yamashita, T. Toyama, Y. Yamamoto, T. Kawasoe, and H. Iwase Reduced expression of the breast cancer metastasis suppressor 1 mRNA is correlated with poor progress in breast cancer. Clin. Cancer Res., November 1, 2006; 12(21): 6410 - 6414. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. E. Norwood, T. J. Moss, N. V. Margaryan, S. L. Cook, L. Wright, E. A. Seftor, M. J. C. Hendrix, D. A. Kirschmann, and L. L. Wallrath A Requirement for Dimerization of HP1Hs{alpha} in Suppression of Breast Cancer Invasion J. Biol. Chem., July 7, 2006; 281(27): 18668 - 18676. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Albini and U. Pfeffer A new tumor suppressor gene: invasion, metastasis, and angiogenesis as potential key targets. J Natl Cancer Inst, June 21, 2006; 98(12): 800 - 801. [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Su, C.-Y. Yang, J.-Y. Shih, L.-H. Wei, C.-Y. Hsieh, Y.-M. Jeng, M.-Y. Wang, P.-C. Yang, and M.-L. Kuo Knockdown of contactin-1 expression suppresses invasion and metastasis of lung adenocarcinoma. Cancer Res., March 1, 2006; 66(5): 2553 - 2561. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. T. Smith, M. Lin, R. M. Brena, J. C. Lang, D. E. Schuller, G. A. Otterson, C. D. Morrison, D. J. Smiraglia, and C. Plass Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23-q24 in lung and head and neck cancer PNAS, January 24, 2006; 103(4): 982 - 987. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. E. Witek, K. Nielsen, R. Walters, T. Hyslop, J. Palazzo, S. Schulz, and S. A. Waldman The Putative Tumor Suppressor Cdx2 Is Overexpressed by Human Colorectal Adenocarcinomas Clin. Cancer Res., December 15, 2005; 11(24): 8549 - 8556. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. Vander Griend, M. Kocherginsky, J. A. Hickson, W. M. Stadler, A. Lin, and C. W. Rinker-Schaeffer Suppression of Metastatic Colonization by the Context-Dependent Activation of the c-Jun NH2-Terminal Kinase Kinases JNKK1/MKK4 and MKK7 Cancer Res., December 1, 2005; 65(23): 10984 - 10991. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Palmieri, D. O. Halverson, T. Ouatas, C. E. Horak, M. Salerno, J. Johnson, W. D. Figg, M. Hollingshead, S. Hursting, D. Berrigan, et al. Medroxyprogesterone Acetate Elevation of Nm23-H1 Metastasis Suppressor Expression in Hormone Receptor-Negative Breast Cancer J Natl Cancer Inst, May 4, 2005; 97(9): 632 - 642. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Steeg New Insights into the Tumor Metastatic Process Revealed by Gene Expression Profiling Am. J. Pathol., May 1, 2005; 166(5): 1291 - 1294. [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Anglesio, V. Evdokimova, N. Melnyk, L. Zhang, C. V. Fernandez, P. E. Grundy, S. Leach, M. A. Marra, A. R. Brooks-Wilson, J. Penninger, et al. Differential expression of a novel ankyrin containing E3 ubiquitin-protein ligase, Hace1, in sporadic Wilms' tumor versus normal kidney Hum. Mol. Genet., September 15, 2004; 13(18): 2061 - 2074. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. K. Mell, J. J. Meyer, M. Tretiakova, A. Khramtsov, C. Gong, S. D. Yamada, A. G. Montag, and A. J. Mundt Prognostic Significance of E-Cadherin Protein Expression in Pathological Stage I-III Endometrial Cancer Clin. Cancer Res., August 15, 2004; 10(16): 5546 - 5553. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Theodorescu, L. M. Sapinoso, M. R. Conaway, G. Oxford, G. M. Hampton, and H. F. Frierson Jr. Reduced Expression of Metastasis Suppressor RhoGDI2 Is Associated with Decreased Survival for Patients with Bladder Cancer Clin. Cancer Res., June 1, 2004; 10(11): 3800 - 3806. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. J. V. Griend, J. C. Berger, and C. W. Rinker-Schaeffer Suppression of Metastasis--A New Function for Known Proteins J Natl Cancer Inst, March 3, 2004; 96(5): 344 - 345. [Full Text] [PDF]
|
|
|
|
 |
|
 D. J. Vander Griend and C. W. Rinker-Schaeffer A New Look at an Old Problem: The Survival and Organ-Specific Growth of Metastases Sci. Signal., January 20, 2004; 2004(216): pe3 - pe3. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. J. Meehan, R. S. Samant, J. E. Hopper, M. J. Carrozza, L. A. Shevde, J. L. Workman, K. A. Eckert, M. F. Verderame, and D. R. Welch Breast Cancer Metastasis Suppressor 1 (BRMS1) Forms Complexes with Retinoblastoma-binding Protein 1 (RBP1) and the mSin3 Histone Deacetylase Complex and Represses Transcription J. Biol. Chem., January 9, 2004; 279(2): 1562 - 1569. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Ouatas, D. Halverson, and P. S. Steeg Dexamethasone and Medroxyprogesterone Acetate Elevate Nm23-H1 Metastasis Suppressor Gene Expression in Metastatic Human Breast Carcinoma Cells: New Uses for Old Compounds Clin. Cancer Res., September 1, 2003; 9(10): 3763 - 3772. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Fu, P. C. Smith, L. Zhang, M. A. Rubin, R. L. Dunn, Z. Yao, and E. T. Keller Effects of Raf Kinase Inhibitor Protein Expression on Suppression of Prostate Cancer Metastasis J Natl Cancer Inst, June 18, 2003; 95(12): 878 - 889. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Bandyopadhyay, S. K. Pai, S. C. Gross, S. Hirota, S. Hosobe, K. Miura, K. Saito, T. Commes, S. Hayashi, M. Watabe, et al. The Drg-1 Gene Suppresses Tumor Metastasis in Prostate Cancer Cancer Res., April 15, 2003; 63(8): 1731 - 1736. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. J. van de Wouw, R. L. H. Jansen, E. J. M. Speel, and H. F. P. Hillen The unknown biology of the unknown primary tumour: a literature review Ann. Onc., February 1, 2003; 14(2): 191 - 196. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. F. Goldberg, M. E. Miele, N. Hatta, M. Takata, C. Paquette-Straub, L. P. Freedman, and D. R. Welch Melanoma Metastasis Suppression by Chromosome 6: Evidence for a Pathway Regulated by CRSP3 and TXNIP Cancer Res., January 15, 2003; 63(2): 432 - 440. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. J. Gildea, M. J. Seraj, G. Oxford, M. A. Harding, G. M. Hampton, C. A. Moskaluk, H. F. Frierson, M. R. Conaway, and D. Theodorescu RhoGDI2 Is an Invasion and Metastasis Suppressor Gene in Human Cancer Cancer Res., November 15, 2002; 62(22): 6418 - 6423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. D. Yamada, J. A. Hickson, Y. Hrobowski, D. J. Vander Griend, D. Benson, A. Montag, T. Karrison, D. Huo, J. Rutgers, S. Adams, et al. Mitogen-activated Protein Kinase Kinase 4 (MKK4) Acts as a Metastasis Suppressor Gene in Human Ovarian Carcinoma Cancer Res., November 15, 2002; 62(22): 6717 - 6723. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Neef, M. A. Kuske, E. Prols, and J. P. Johnson Identification of the Human PHLDA1/TDAG51 Gene: Down-Regulation in Metastatic Melanoma Contributes to Apoptosis Resistance and Growth Deregulation Cancer Res., October 15, 2002; 62(20): 5920 - 5929. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. T. Hartsough, D. K. Morrison, M. Salerno, D. Palmieri, T. Ouatas, M. Mair, J. Patrick, and P. S. Steeg Nm23-H1 Metastasis Suppressor Phosphorylation of Kinase Suppressor of Ras via a Histidine Protein Kinase Pathway J. Biol. Chem., August 23, 2002; 277(35): 32389 - 32399. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. T. Cheung, X. Chen, X. Y. Guan, S. Y. Wong, L. S. Tai, I. O. L. Ng, S. So, and S. T. Fan Identify Metastasis-associated Genes in Hepatocellular Carcinoma through Clonality Delineation for Multinodular Tumor Cancer Res., August 15, 2002; 62(16): 4711 - 4721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. A. Kirschmann, E. A. Seftor, S. F. T. Fong, D. R. C. Nieva, C. M. Sullivan, E. M. Edwards, P. Sommer, K. Csiszar, and M. J. C. Hendrix A Molecular Role for Lysyl Oxidase in Breast Cancer Invasion Cancer Res., August 1, 2002; 62(15): 4478 - 4483. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. G. Meadows, H. Zhang, and X. Ge Specific Amino Acid Deficiency Alters the Expression of Genes in Human Melanoma and Other Tumor Cell Lines J. Nutr., November 1, 2001; 131(11): 3047S - 3050. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Steeg Collapsin Response Mediator Protein-1: a Lung Cancer Invasion Suppressor Gene With Nerve J Natl Cancer Inst, September 19, 2001; 93(18): 1364 - 1365. [Full Text] [PDF]
|
|
|
|
|
|
J.-Y. Shih, S.-C. Yang, T.-M. Hong, A. Yuan, J. J. W. Chen, C.-J. Yu, Y.-L. Chang, Y.-C. Lee, K. Peck, C.-W. Wu, et al. Collapsin Response Mediator Protein-1 and the Invasion and Metastasis of Cancer Cells J Natl Cancer Inst, September 19, 2001; 93(18): 1392 - 1400. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Zafon, G. Obiols, J. CastellvI, N. Tallada, P. Galofre, E. Gemar, J. Mesa, and R. Simo nm23-H1 Immunoreactivity as a Prognostic Factor in Differentiated Thyroid Carcinoma J. Clin. Endocrinol. Metab., August 1, 2001; 86(8): 3975 - 3980. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Xia, P. Unger, L. Miller, J. Nelson, and I. H. Gelman The Src-suppressed C Kinase Substrate, SSeCKS, Is a Potential Metastasis Inhibitor in Prostate Cancer Cancer Res., July 1, 2001; 61(14): 5644 - 5651. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. L. Kim, D. J. Vander Griend, X. Yang, D. A. Benson, Z. Dubauskas, B. A. Yoshida, M. A. Chekmareva, Y. Ichikawa, M. H. Sokoloff, P. Zhan, et al. Mitogen-activated Protein Kinase Kinase 4 Metastasis Suppressor Gene Expression Is Inversely Related to Histological Pattern in Advancing Human Prostatic Cancers Cancer Res., April 1, 2001; 61(7): 2833 - 2837. [Abstract] [Full Text]
|
|